Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma
Clinical trial NCT04493203 · COMPLETED
Trial details
- NCT number
- NCT04493203
- Sponsor
- Yana Najjar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2024-04-15
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.